Criteria for Highly Variable Drug Products in Bioequivalence Studies
Criteria for Highly Variable Drug Products in Bioequivalence Studies Bioequivalence Strategies for Highly Variable Drugs: Criteria and Compliance Introduction: Defining Highly Variable Drugs in BE Context Highly Variable Drug Products (HVDs) present a significant challenge in designing and analyzing bioequivalence (BE) studies. According to FDA and EMA definitions, a drug is considered highly variable if…
Read More “Criteria for Highly Variable Drug Products in Bioequivalence Studies” »